文献速递肥胖与代谢综合征糖尿病

减重可部分恢复人类葡萄糖驱动的促胰岛β细胞增生因子反应

Weight Loss Partially Restores Glucose-Driven Betatrophin Response in Humans.
PubMed 文献 · J Clin Endocrinol Metab · 2016-07-26

研究比较12名瘦者与20名肥胖者口服葡萄糖后促胰岛β细胞增生因子(betatrophin)反应,肥胖者空腹水平较低且葡萄糖负荷后抑制更明显;12周结构化减重后该反应恢复至与瘦者相当。体外3T3-L1脂肪细胞实验显示胰岛素和低糖增加表达,进一步高糖削弱此效应。

要点

  • 口服葡萄糖后促胰岛β细胞增生因子水平下降(P < .001),与血糖升高相关(r = -0.396;P < .05)。
  • 肥胖者空腹促胰岛β细胞增生因子较低(600.6 ± 364.4 vs 759.5 ± 197.9 pg/mL;P < .05),葡萄糖负荷后抑制更明显。
  • 12周结构化减重后肥胖者受损的促胰岛β细胞增生因子反应恢复,与瘦者相当。

核心结论

  • 肥胖与口服葡萄糖负荷后促胰岛β细胞增生因子抑制增强相关,由高血糖加重驱动。
  • 鉴于促胰岛β细胞增生因子的代谢特性,这可能提示其与肥胖相关代谢紊乱紧密相连。
  • 减重几乎完全消除了这一现象。

研究设计与样本

  • 在内分泌研究中心对12名瘦者(基线)和20名肥胖者(12周结构化减重前后)行口服葡萄糖负荷。
  • 在肥胖队列中行正常血糖高胰岛素钳夹试验。
  • 在3T3-L1脂肪细胞中分析胰岛素和不同葡萄糖浓度对促胰岛β细胞增生因子表达的影响。

主要发现

  • 口服葡萄糖摄入后促胰岛β细胞增生因子水平下降(P < .001)。
  • 促胰岛β细胞增生因子下降与葡萄糖水平升高相关(r = -0.396;P < .05)。
  • 高胰岛素血症导致促胰岛β细胞增生因子增加。
  • 体外3T3-L1脂肪细胞实验证实胰岛素和低葡萄糖浓度增加促胰岛β细胞增生因子表达,而葡萄糖水平进一步升高削弱此效应。
  • 肥胖者空腹促胰岛β细胞增生因子较低(600.6 ± 364.4 vs 759.5 ± 197.9 pg/mL;P < .05),葡萄糖负荷期间抑制更明显;减重后受损反应恢复,与瘦者相当。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Recently a potential role of betatrophin was shown in the postprandial switch from lipid to glucose metabolism. OBJECTIVE: The objective of the study was to analyze whether obesity is associated with altered postprandial betatrophin response and whether this could be restored by weight loss. Design, Setting, Participants, and Intervention: Oral glucose load was performed in 12 lean individuals at baseline as well as in 20 obese subjects before and after a 12-week structured weight-loss program at an endocrinology research center. Euglycemic hyperinsulinemic clamps were performed in the obese cohort. The effect of insulin and different glucose concentrations on betatrophin expression were analyzed in 3T3-L1 adipocytes. MAIN OUTCOME MEASURE: Circulating betatrophin levels during a glucose challenge were measured. RESULTS: The betatrophin level decreases after an oral glucose intake (P < .001). This correlates with the increase of glucose levels (r = -0.396; P < .05). Hyperinsulinemia results in an increase of betatrophin. In vitro experiments in 3T3-L1 adipocytes confirmed that insulin and low glucose concentration increases betatrophin expression, whereas a further elevation of glucose levels blunts this effect. Obese subjects are characterized by lower fasting betatrophin (600.6 ± 364.4 vs 759.5 ± 197.9 pg/mL; P < .05) and a more pronounced betatrophin suppression during the glucose challenge. The impaired betatrophin response in obese subjects is restored after weight loss and is comparable with lean individuals. CONCLUSIONS: Obesity is associated with increased betatrophin suppression after an oral glucose load, which is driven by increased hyperglycemia. Given the metabolic properties of betatrophin, this may indicate that betatrophin is tightly linked to obesity-associated metabolic disturbances. In line with such an assumption, weight loss almost completely eliminated this phenomenon.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Maurer L, Brachs S, Decker AM, et al. Weight Loss Partially Restores Glucose-Driven Betatrophin Response in Humans. J Clin Endocrinol Metab. 2016. PMID: 27459526

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。